Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Centers for Disease Control and Prevention · National Center for Immunization and Respiratory Diseases · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
727
total citations
- FWCI
- 68.80
- Percentile
- 100%
- References
- 33
Citations per year
Authors
22- MRMatthew R. MooreCorresponding
Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases
- RLRuth Link‐Gelles
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
- WSWilliam Schaffner
Vanderbilt University
- RLRuth Lynfield
Minnesota Department of Health
- CLCatherine Lexau
Minnesota Department of Health
Topics & keywords
Topics
Keywords
- Pneumococcal conjugate vaccine
- Pneumococcal disease
- Medicine
- Incidence (geometry)
- Pediatrics
- Population
- Serotype
- Streptococcus pneumoniae
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.